Indole derivatives as neuroprotectants

Life Sciences

Volumn 65, Issue 18-19, 1999, Pages 1943-1950

  Štolc, Svorad ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Antioxidants; Carvedilol; Free radical scavengers; Melatonin; Neurotoxicity; Reactive oxygen species; Stobadine; U 101033E

Indexed keywords

ANTIOXIDANT; CARBAZOLE DERIVATIVE; CARBOLINE DERIVATIVE; CARVEDILOL; INDOLE DERIVATIVE; INDOLEAMINE; MELATONIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; VINPOCETINE;

BRAIN HYPOXIA; BRAIN ISCHEMIA; CONFERENCE PAPER; DISEASE MODEL; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REOXYGENATION; REPERFUSION; STRUCTURE ANALYSIS;

ANIMALS; HUMANS; INDOLES; NEUROPROTECTIVE AGENTS;

LETHRINIDAE;

EID: 0033213511     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00453-1     Document Type: Conference Paper

References (69)

1. J.M. Braughler and E.D. Hall, Free Radic. Biol. Med. 6 289-301 (1989).
2. E.D. Hall and J.M. Braughler, Free Radic. Biol. Med. 6 303-315 (1989).
3. R.A. Floyd, FASEB J. 4 2587-2597 (1990).
4. J.M. Carney, P. Gabbita, S. Yatin, M. Aksenova, M. Aksenov and A. Butterfield, Life Sci. - The Current Issue (1998).
5. M.R. DeFilipis, C.P. Murthy, M. Faraggi and M.H. Klapper, Biochemistry 28 4847-4853 (1989).
6. L'. Horáková, A. Giessauf, G. Raber and H. Esterbauer, Biochem. Pharmacol. 51 1277-1282 (1996).
7. Anonym, Index Merck, E.Merck A.G., Darmstadt, (1961)
8. T.Y. Chang and P.L. Tang, J. Pineal Res. 20 187-191 (1996).
9. V. Kumar, Indian J. Exp. Biol. 34 391-402 (1996).
10. W. Pierpaoli and V. Lesnikov, Gerontology 43 20-25 (1997).
11. R.J. Reiter, FASEB J. 9 526-533 (1995).
12. R.M. Sainz, J.C. Mayo, H. Uria, M. Kotler, I. Antolín, C. Rodriguez and A. Pelaez-Menendez, J. Pineal Res. 19 178-188 (1995).
13. E. Gilad, S. Cuzzocrea, B. Zingarelli, A.L. Salzman and C. Szabó, Life Sci. 60 169-174 (1997).
14. K.A. Marshall, R.J. Reiter, B. Poeggeler, O.I. Aruoma and B. Halliwell, Free Radic. Biol. Med. 21 307-315 (1996).
15. C.M. Cagnoli, C. Atabay, E. Kharlamova and H. Manev, J. Pineal Res. 18 222-226 (1995).
16. L.C. Manchester, B. Poeggeler, F.L. Alvarez, G.B. Ogden and R.J. Reiter, Cell. Mol. Biol. Res. 41 391-395 (1995).
17. F. Lezoualc'h, T. Skutella, M. Widmann and C. Behl, Neuroreport 7 2071-2077 (1966).
18. P. Giusti, M. Lipartiti, D. Franceschini, N. Schiavo, M. Floreani and H. Manev, FASEB J. 10 891-896 (1996).
19. D. Acuna-Castroviejo, A. Coto-Montes, M. Gaia Monti, G.G. Ortiz and R.J. Reiter, Life Sci. 60 PL23-PL29 (1997).
20. M.A. Pappolla, M. Sos, R.A. Omar, R.J. Bick, D.L. Hickson-Bick, R.J. Reiter, S. Efthimiopoulos and N.K. Robakis, J. Neurosci. 17 1683-1690 (1997).
21. C.P. Maurizi, Med. Hypotheses 45 339-340 (1995).
22. R. Vlkolinský, S. Štolc and A. Ross, Life Sci. - The Current Issue (1998).
23. G.Z. Feuerstein, T.L. Yue, H.Y. Cheng and R.R. Ruffolo Jr., J. Hypertens. Suppl. 11 S-41-48 (1993).
24. T.L. Yue, P.G. Lysko, F.C. Barone, J.L. Gu, R.R. Ruffolo Jr. and G.Z. Feuerstein, Ann. N. Y. Acad. Sci. 17 230-242 (1994).
25. P.G. Lysko, G.Z. Feuerstein and R.R. Ruffolo Jr., Pharmaceut. News 2 12-16 (1995).
26. R. Feuerstein and T.L. Yue, Pharmacology 48 385-391 (1994).
27. M.A. Cotter and N.E. Cameron, Nauyn Schmiedebergs Arch. Pharmakol. 351 630-635 (1995).
28. F.C. Barone, A.H. Nelson, E.H. Ohlstein, R.N. Willette, J.E. Sealey, J.H. Laragh, W.G. Campbell Jr. and G.Z. Feuerstein, J. Pharmacol. Exp. Ther. 279 948-955 (1996).
29. G.Z. Feuerstein and R.R. Ruffolo Jr., Eur. Heart J. 17 Suppl. B 24-29 (1996).
30. Kawashima, A. Horiguchi, M. Taguchi, Y. Tuyuki, Y. Karasawa, H. Araki and K. Hatayama, Chem. Pharm. Bull. (Tokyo) 43 783-787 (1995).
31. G. Domány, A. Gere, M. Paróczai, I. Schön, C. Szántay Jr., M. Bihari, B. Hegedûs, B. Kiss, E. Kárpáti and C. Szántay, in: Oxygen Free Radicals and Scavengers in the Natural Sciences, G. Mózsik et al. (eds), 109-112, Akadémiai Kiadó, Budapest (1993).
32. M. Paróczai, A. Gere and E. Kárpáti, in: Oxygen Free Radicals and Scavengers in the Natural Sciences, G. Mózsik et al. (eds), 259-266, Akadémiai Kiadó, Budapest (1993).
33. C. Lörincz, K. Szász and L. Kisfaludy, Arzneim. Forsch. Drug Res. 26 1907 (1976).
34. Anonym, Cavinton, Gedeon Richter Ltd., Medicina 30.4034, Budapest, Hungary (1981).
35. D. Sauer, R. Rischke, T. Beck, C. Rossberg, H.D. Mennel, G.W. Bielenberg and J. Krieglstein, Life Sci. 43 1733-1739 (1988).
36. T. Araki, K. Kogure and K. Nishioka, Res. Exp. Med. (Berlin) 1 19-23 (1990).
37. R. Rischke and J. Krieglstein, Jap. J. Pharmacol. 56 349-356 (1991).
38. V.A. Oláh, G. Balla, J. Balla, A. Szabolcs and L. Karmazsin, Acta Paediatr. Hung. 30 309-316 (1990).
39. H. Raza, R.S. King, R.B. Squires, F.P. Guegenrich, D.W. Miller, J.P. Freeman, N.P. Lang and F.F. Kadlubar, Drug Metab. Dispos. 24 395-400 (1996).
40. B. Malgrange, J.M. Rigo, P. Coucke, W. Belachew, B. Rogister and G. Moonen, Neuroreport 7 3041-3045 (1996).
41. B. Janetzky, R. God, G. Bringmann and H. Reichmann, J. Neural Transm. Suppl. 46 365-273 (1995).
42. C. Heim and K.H. Sonntag, J. Neural Transm. Suppl. 50 107-111 (1997).
43. C. De Meester, Mutat. Res. 339 139-153 (1995).
44. W. Kuhn, T. Müller, H. Grosse and H. Rommelspacher, J. Neural. Trans. Suppl. 46 291-295 (1995).
45. S. Štolc, V. Bauer, L. Beneš and M. Tichý, Patents: CS 229067, Swed. 8204693-9, Belg. 894148, Swiss 651754, BRD P-3231088, Spain 553017, Jap. 1514040 (1983).
46. L'. Horáková, H. Sies and S. Steenken, Methods Enzymol. 234 572-580 (1994).
47. S. Štolc, R. Vlkolinský and J. Pavlásek, Brain Res. Bull. 42 335-340 (1997).
48. L'. Horáková and S. Štolc, Gen. Pharmacol. 30 627-638 (1998).
49. th Pharmacol.Days, Šafárik University Med. School, Košice, Slovak Republic (1997).
50. S. Štolc, Pharmacol. Commun. 4 277-284 (1994).
51. S. Štolc and J. Selecká, Mol. Chem. Neuropathol. 25 199-212 (1995).
52. L'. Horáková, V. Uraz, O. Ondrejičková, L'. Lukovič and I. Juránek, Biomed. Biochem. Acta 50 1019-1025 (1991).
53. M. Pomfy, J. Franko, B. Nováková, J. Maršala and J. Škuba, J. Brain Res. 36 365-378 (1995).
54. Z. Kvaltínová and S. Štolc, Ann. N. Y. Acad. Sci. 812 240-242 (1997).
55. A. Staško, K. Ondriaš, V. Mišík, H. Szösová and D. Gergel', Chem. Papers 44 493-500 (1990).
56. M. Štefek, M. Masaryková and L. Beneš, Pharmacol. Toxicol. 70 407-411 (1992).
57. V.E. Kagan, M. Tsuchyia, E. Serbinova, L. Packer and H. Sies, Biochem. Pharmacol. 45 393-400 (1993).
58. L'. Horáková, R.J Schaur, P. Balgavý and G. Egger, Redox Report 1 369-372 (1995).
59. L'. Horáková, R.J. Schaur and P. Balgavý, Redox Report 2 401-405 (1996).
60. S. Steenken, A.R. Sundquist, S.V. Jovanovic, R. Crockett and H. Sies, Chem. Res. Toxicol. 5 355-360. (1992).
61. S. Štolc and L'. Horáková, New Trends in Clinical Neuropharmacology, D. Bartko, P. Turčáni and G. Stern (eds), 59-63, John Libbey and Co. Ltd., London (1988).
62. P. Račay, P. Kaplán, J. Lehotský and V. Mézešová, Biochem. Mol. Biol. Int. 36 569-577 (1995).
63. V. Jančinová and R. Nosál', Life Sci. - The Current Issue (1998).
64. Z. Kállay, J. Bittererová, A. Brejcha, V. Faberová, Š. Bezek and T. Trnovec, Arzneimitt. Forsch./Drug Res. 40 974-979 (1990).
65. J. Pavlásek, M. Haburčák, C. Mašánová and S. Štolc, Physiol. Res. 45 193-204 (1996).
66. A. Drgová, J. Jakuš, V. Mézešová, D. Dobrota and V. Mézeš, p. 113 in: Abstr. from XIVth Biochem.Conf., Slovak Techn.Univ., Bratislava (1995).
67. A. Gajdošíková, E. Ujházy, A. Gajdošík, I. Chalupa, M. Blaško, A. Tomášková, J. Liška, M. Dubovický and V. Bauer, Arzneimitt. Forsch/Drug Res. 45 531-536 (1995).
68. G.L. Bundy, D.E. Ayer, L.S. Banitt, K.L. Belonga, A. Stephen, J.R. Palmer, J.M. Tustin, J.E. Chin, E.D. Hall et al., J. Med. Chem. 38 4161-4163 (1995).
69. E.D. Hall, P.K. Andrus, J.A. Oostveen, S.L. Smith, D.B. Carter, E.D. Dunn, H.M. Scherch and P.F. Von Voigtlander, p. 25 in: Abstr. from neurodegenerative diseases '95: Molec. cell. mech. and therapeut. advances., XVth Washington Spring Symp., Washington D.C., (1995).